YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
NSF
Dialysis, Kidney Transplant Patients Face Higher Risk of NSF from Gadolinium Agents
Nov 20, 2009 | Parker Waichman Alonso LLP
A study of patients exposed to gadolinium contrast dyes at the Mayo Clinic has revealed that hemodialysis patients had a 77-fold higher...
OptiMARK Gadolinium Contrast Agent Label Changed Over NSF Risk
Nov 19, 2009 | Parker Waichman Alonso LLP
The maker of OptiMARK gadolinium contrast agent is modifying the product's label to contraindicate its use in patients with severe kidney impairment...
Magnevist, Omniscan and OptiMARK Have Highest Risk of NSF, FDA Says
Nov 18, 2009 | Parker Waichman Alonso LLP
Three gadolinium contrast dyes - Bayer Healthcare's Magnevist, GE Healthcare's Omniscan, and Covidien 's OptiMARK -carry a higher risk of...
Study Suggests "Potent" Link Between NSF, Gadolinium Contrast Dyes
Apr 3, 2009 | Parker Waichman Alonso LLP
Another study has found a strong link between the use of gadolinium contrast dyes and the development of Nephrogenic Systemic Fibrosis...
Gadolinium Contrast Dye Lawsuit Trials Will Start in January
Mar 25, 2009 | Parker Waichman Alonso LLP
The first civil trials involving gadolinium MRI contrast dyes are scheduled to begin early next year. Hundreds of lawsuits have been filed against...
Gadolinium Contrast Dye Risks Can be Reduced Through Screening
Feb 5, 2009 | Parker Waichman Alonso LLP
A new study has found that clinicians can reduce the chances that kidney patients exposed to gadolinium contrast dyes will develop Nephrogenic...
Vasovist Approved for MRA Procedures
Dec 29, 2008 | Parker Waichman Alonso LLP
Federal health regulators have approved a new gadolinium contrast agent for use in magnetic resonance angiography, or MRA. The Food & Drug...
Another Study Links NSF to Gadolinium Contrast Dyes
Oct 14, 2008 | Parker Waichman Alonso LLP
A new study of people with Nephrogenic Systemic Fibrosis (NSF) has again found a strong link between the condition and the use of gadolinium...
NSF Lawsuits Moving Ahead in Multidistrict Litigation
Oct 1, 2008 | Parker Waichman Alonso LLP
Lawsuits filed by people claiming that gadolinium contrast agents caused them to develop Nephrogenic Systemic Fibrosis (NSF) are moving forward in...
Hemodialysis After MRI with Gadolinium Could Prevent NSF in Some Kidney Patients
Aug 21, 2008 | Parker Waichman Alonso LLP
A new study indicates that some kidney patients who undergo hemodialysis following exposure to gadolinium contrast dyes during an MRI may...
Diseases
